| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |